Billiontoone Class A Stock Today
| BLLN Stock | 90.61 5.46 6.41% |
PerformanceWeakest
| Odds Of DistressLow
|
BillionToOne is selling at 90.61 as of the 7th of February 2026; that is 6.41 percent up since the beginning of the trading day. The stock's open price was 85.15. BillionToOne has about a 20 % chance of experiencing some form of financial distress in the next two years of operation but has generated negative returns over the last 90 days. The performance scores are derived for the period starting the 9th of November 2025 and ending today, the 7th of February 2026. Click here to learn more.
Business Domain Health Care Equipment & Services | IPO Date 6th of November 2025 | Category Healthcare | Classification Health Care |
BillionToOne is entity of United States. It is traded as Stock on NASDAQ exchange. The company has 41.22 M outstanding shares of which 712.19 K shares are currently shorted by private and institutional investors with about 2.81 trading days to cover. More on BillionToOne Class A
Moving against BillionToOne Stock
Follow Valuation Profit Patterns Odds of Bankruptcy
Check how we calculate scores
BillionToOne Stock Highlights
| Chairman CoFounder | Oguzhan Atay | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Business Concentration | Health Care Equipment & Supplies, Health Care Equipment & Services, Health Care, NASDAQ Composite, NASDAQ Health Care, Health Care, Health Care Equipment & Supplies, Diagnostics & Research, Healthcare (View all Sectors) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Financial Strength
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt LevelsBillionToOne utilizes debt financing to potentially enhance returns on invested capital. The relationship between total debt and total assets provides valuable insight into BillionToOne's leverage profile, showing how much of BillionToOne's resources are funded through borrowing. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
BillionToOne Class A (BLLN) is traded on NASDAQ Exchange in USA and employs 620 people. BillionToOne is listed under Health Care Equipment & Supplies category by Fama And French industry classification. The company currently falls under 'Mid-Cap' category with a current market capitalization of 4.01 B. BillionToOne Class conducts business under Health Care Equipment & Supplies sector and is part of Health Care industry. The entity has 41.22 M outstanding shares of which 712.19 K shares are currently shorted by private and institutional investors with about 2.81 trading days to cover.
BillionToOne generates negative cash flow from operations
Check BillionToOne Probability Of Bankruptcy
Ownership AllocationBillionToOne holds a total of 41.22 Million outstanding shares. BillionToOne Class A retains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check BillionToOne Ownership Details
BillionToOne Historical Income Statement
BillionToOne Stock Against Markets
BillionToOne Corporate Management
| MBA Taylor | Chief Officer | Profile | |
| Nancy Johnson | Senior Operations | Profile | |
| Shan MBA | Chief Officer | Profile | |
| Jaclyn Eng | Vice Marketing | Profile | |
| Thomas JD | General Officer | Profile |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in BillionToOne Class A. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.
Will Health Care Equipment & Supplies sector continue expanding? Could BillionToOne diversify its offerings? Factors like these will boost the valuation of BillionToOne. Projected growth potential of BillionToOne fundamentally drives upward valuation adjustments. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every BillionToOne data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
The market value of BillionToOne Class is measured differently than its book value, which is the value of BillionToOne that is recorded on the company's balance sheet. Investors also form their own opinion of BillionToOne's value that differs from its market value or its book value, called intrinsic value, which is BillionToOne's true underlying value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Because BillionToOne's market value can be influenced by many factors that don't directly affect BillionToOne's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
It's important to distinguish between BillionToOne's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding BillionToOne should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Meanwhile, BillionToOne's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.